Abstract:The activation of hepatic stellate cells (HSCs) is closely related to hepatic fibrosis and plays a key role in its occurrence and development. In the damaged liver, inhibition of the activation, proliferation, and clearance of HSCs is an important therapeutic strategy. However, the mechanism underlying the activation of HSCs is not completely clear. Acid-sensitive ion channel 1a (ASIC1a) is a cation channel activated by extracellular acid, which is responsible for the transport of Ca 2+ and Na + and participates in the activation of HSCs and the occurrence and development of many inflammatory diseases, suggesting that ASIC1a plays an important role in liver fibrosis. A previous study by the project team found that when the membrane channel protein ASIC1a was opened, intracellular Ca 2+ levels increased, the expression of CaM/CaMKII in HSCs was high, and HSC was activated and proliferated. Therefore, we established an SD rat model of hepatic fibrosis and induced HSC-T6 activation by stimulating ASIC1a with acid in vitro. In vivo, CCl 4 was used to induce liver fibrosis in rats, and different doses of KN93 (0.5, 1, and 2 mg/kg/d) and colchicine (0.1 mg/kg/d) were administered. Eight weeks later, the activities of ALT and AST in serum were measured and hematoxylin-eosin and Masson staining in liver tissue, and immunohistochemistry analysis were performed in SD rats. The expressions of ASIC1a, α-SMA, Collagen-1, CaM, and CaMKII were detected. In vitro, we activated HSC-T6 cells by stimulating ASIC1a with acid. The results showed that inhibition of ASIC1a could improve acid-induced HSCs activation. In addition, CaM/CaMKII was expressed in HSC of rats with hepatic fibrosis regulated by ASIC1a. After blocking or silencing the expression of CaMKII, the fibrosis marker protein can be down-regulated. KN93 also reduced inflammation and improved the activation, proliferation and fibrosis of HSC. In summary, we concluded that CaM/CaMKII participates in ASIC1a regulation of the proliferation and activation of HSC and promotes the occurrence of liver fibrosis.

Activin A plays an essential role in migration and proliferation of hepatic stellate cells via Smad3 and calcium signaling

Increased Smad1 expression and transcriptional activity enhances trans-differentiation of hepatic stellate cells.

[Mechanism of Hepatic Stellate Cell Migration During Liver Fibrosis].

Effects of activin A on proliferating activity of hepatic stellate cell line LI 90

Activin on Extracellular Matrix Secretion in Isolated Rat Hepatic Stellate Cells

Activin A As A Novel Chemokine Induces Migration Of L929 Fibroblasts By Erk Signaling In Microfluidic Devices

Migration Of Hepatic Stellate Cells In Fibrotic Microenvironment Of Diseased Liver Model

Effects of fibrogenetic growth factors on migration of hepatic stellate cells

Role of Macrophage Migration Inhibitory Factor in Hepatic Stellate Cells Activation

Wnt5a Promotes Cytokines Production and Cell Proliferation in Human Hepatic Stellate Cells Independent of Canonical Wnt Pathway.

Transforming Growth Factor-1 Downregulation of Smad 1 Gene Expression in Rat Hepatic Stellate Cells

TGF-β1 activates mouse hepatic stellate cells through Jagged1/Notch

TGF-β1 Activated Hepatic Stellate Cells Induce Angiogenesis of Vascular Endothelial Cells

SAA1/TLR2 axis directs chemotactic migration of hepatic stellate cells responding to injury

Effect of RhoA on transforming growth factor β1-induced rat hepatic stellate cell migration.

CaM/CaMKII mediates activation and proliferation of hepatic stellate cells regulated by ASIC1a

Effects of all-trans retinioc acid on expressions of COL1α2,MMP-2,TIMP-1, and signaling pathway in TGF-β1-simulated rat hepatic stellate cells

[Effect of Protein Kinase C/transforming Growth Factor Beta 1 Pathway on Activation of Hepatic Stellate Cells].

Ca2+/calmodulin‐ Dependent Protein Kinase II Mediates Transforming Growth Factor‐β‐induced Hepatic Stellate Cells Proliferation but Not in Collagen Α1(i) Production

Activin A Stimulates the Proliferation and Differentiation of Cardiac Fibroblasts Via the ERK1/2 and P38-Mapk Pathways

Molecular mechanism of hepatic stellate cell activation and antifibrotic therapeutic strategies